0000950170-24-064274.txt : 20240523
0000950170-24-064274.hdr.sgml : 20240523
20240523215437
ACCESSION NUMBER: 0000950170-24-064274
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240522
FILED AS OF DATE: 20240523
DATE AS OF CHANGE: 20240523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hughes-Wilson Alexandra
CENTRAL INDEX KEY: 0002005875
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38452
FILM NUMBER: 24980680
MAIL ADDRESS:
STREET 1: C/O MEREO BIOPHARMA
STREET 2: 1 CAVENDISH PLACE
CITY: LONDON
STATE: X0
ZIP: W1G 0QF
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mereo BioPharma Group plc
CENTRAL INDEX KEY: 0001719714
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE CAVENDISH PLACE
STREET 2: FOURTH FLOOR
CITY: LONDON
STATE: X0
ZIP: W1G0QF
BUSINESS PHONE: 4403330237300
MAIL ADDRESS:
STREET 1: ONE CAVENDISH PLACE
STREET 2: FOURTH FLOOR
CITY: LONDON
STATE: X0
ZIP: W1G0QF
FORMER COMPANY:
FORMER CONFORMED NAME: Mereo Biopharma Group plc
DATE OF NAME CHANGE: 20171016
4
1
ownership.xml
4
X0508
4
2024-05-22
0001719714
Mereo BioPharma Group plc
MREO
0002005875
Hughes-Wilson Alexandra
C/O MEREO BIOPHARMA GROUP PLC
4TH FLOOR, ONE CAVENDISH PLACE
LONDON
X0
W1G 0QF
UNITED KINGDOM
false
true
false
false
See Remarks
false
American Depositary Shares representing Ordinary Shares
2024-05-22
4
M
false
93333
1.4
A
100983
D
American Depositary Shares representing Ordinary Shares
2024-05-22
4
S
false
50350
2.99
D
58633
D
American Depositary Shares representing Ordinary Shares
2024-05-22
4
F
false
42983
1.40
D
7650
D
American Depositary Shares representing Ordinary Shares
2024-05-22
4
M
false
75000
1.01
A
82650
D
American Depositary Shares representing Ordinary Shares
2024-05-22
4
S
false
50082
2.94
D
32568
D
American Depositary Shares representing Ordinary Shares
2024-05-22
4
F
false
24918
1.01
D
7650
D
Share Options (Right to buy)
1.40
2024-05-22
4
M
false
93333
1.40
D
2032-01-14
American Depositary Shares
93333
0
D
Share Options (Right to buy)
1.01
2024-05-22
4
M
false
75000
1.01
D
2033-01-25
American Depositary Shares
75000
0
D
Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.
Ms. Hughes-Wilson sold a total of 100,432 ADSs solely to pay a tax obligation, and all proceeds are being used for such taxes.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $2.88 to $3.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges
160,000 options were issued on 01/14/2022 and 25% of the shares underlying this award became exercisable on January 14, 2023, with the remainder vesting in equal monthly installments thereafter.
240,000 options were issued on 01/25/2023 and 25% of the shares underlying this award became exercisable on January 25, 2024, with the remainder vesting in equal monthly installments thereafter.
Chief Patient Access and Commercial Planning
/s/ Christine Fox, by power of attorney
2024-05-23